One of the most highly anticipated offerings of the ATS International Conference, the Clinical Year in Review, will begin Sunday, May 19. The four-part series will be presented in daily sessions through Wednesday, May 22.

“The Clinical Year in Review is an opportunity to get in touch with state-of-the-art topics and evolving ideas in pulmonary, critical care, and sleep medicine,” explained Clinical Year in Review Co-Chair Juliana C. Ferreira, MD, PhD, ATSF, University of Sao Paulo, Brazil. “Attendees will be immersed in a carefully curated review of the latest literature by emerging leaders in the field. After the conference, participants will have a more profound understanding of innovative concepts in each specific area, enabling them to integrate these advancements into patient care.”

Each session will feature four speakers, each highlighting four to six of the most relevant articles in their respective fields of expertise from the previous year, providing attendees with a comprehensive understanding of the latest, most pertinent, and influential developments in each presented topic.

This year’s lineup includes a mix of new and returning topics.

Sunday, May 19, 9:15-10:45 a.m. PT

• ARDS, presented by Shewit Giovanni, MD, MSCE, Oregon Health & Science University
• Asthma, presented by Juan Carlos Cardet, MD, MPH, University of South Florida
• Health Equity, presented by Aaron Dorian Baugh, MD, University of California, San Francisco
• Lung Cancer, presented by Matthew Triplette, MD, MPH, Fred Hutchinson Cancer Center

Monday, May 20, 9:15-10:45 a.m. PT

• COPD, presented by Wassim Walid Labaki, MD, MS, University of Michigan
• Critical Care, presented by Anica Law, MD, MSci, Boston University
• Global Lung Health, presented by Daniel O. Obaseki, MD, ATSF, Obafemi Awolowo University, Nigeria
• Tuberculosis, presented by Sara Auld, MD, MSc, Emory University

Tuesday, May 21, 9:15-10:45 a.m. PT

• Interstitial Lung Disease, presented by Deborah Assayag, MD, CM, McGill University, Montreal, Canada
• Medical Education, presented by Diana Kelm, MD, ATSF, Mayo Clinic
• Sepsis, presented by Ithan D. Peltan, MD, MSc, Intermountain Medical Center
• Occupational/Environmental Lung Disease, presented by Sheiphali Gandhi, MD, MPH, CTropMed, University of California, San Francisco

Wednesday, May 22, 8:15-9:45 a.m. PT

• Tobacco Control, presented by Daniel Croft, MD, MPH, ATSF, University of Rochester Medical Center
• ECMO, presented by Tài Pham, MD, PhD, MPH, Hôpital de Bicêtre, APHP, France
• Pulmonary Vascular Disease, presented by Silvia Ulrich, MD, University Hospital of Zurich, Switzerland
• Sleep, presented by Alejandra Carolina Lastra, MD, Rush University Medical Center

“We are thrilled to introduce global lung health as a topic in the Clinical Year in Review for the first time this year. Medicine is continually evolving, and the scientific sessions at the International Conference endeavor to remain current, offering attendees the latest updates,” Dr. Ferreira said. “Certain topics, like tuberculosis, have seen significant clinical trial advancements in the previous year, and we aim to ensure that attendees are informed about these developments, enabling them to apply the latest clinical evidence in their practice when they return home from the conference.”

Dr. Ferreira will be joined by Co-Chairs Sara Auld, MD, MSc, Emory University, and Ayodeji O. Adegunsoye, MD, MS, University of Chicago.

“As we plan the sessions, the chairs review topics from recent years to ensure a well-rounded representation across various subjects in pulmonary, critical care, and sleep medicine,” Dr. Ferreira said. “We aim for a blend of recurrent themes covering prevalent respiratory diseases like asthma, alongside emerging or trending topics, such as COVID-19 over the last two years, and other significant subjects that may have had impactful publications in the previous year.”

These sessions and the International Conference are supported by an independent medical educational grant from Chiesi USA, Inc.; Mallinckrodt Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Insmed Incorporated; Merck & Co., Inc.; United Therapeutics Corporation; and GSK. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).